5 Results for "

Tricalcium

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Tricalcium" in MCE Product Catalog:

Cat. No.: HY-D0833
CAS No.: 7758-87-4
Tricalcium phosphate is a kind of biological materials or organic compounds that are widely used in life science research .
loading...
    loading...
Cat. No.: HY-W094517
CAS No.: 7782-85-6
Sodium phosphate dibasic heptahydrate is an orally active and osmotic laxative, often used as a component of over-the-counter gastrointestinal lavage drugs. Sodium phosphate dibasic heptahydrate draws water into the intestinal lumen, maintains electrical neutrality by retaining cations in the intestinal lumen, and thereby alters fecal volume, consistency and phosphate levels. Sodium phosphate dibasic heptahydrate can be used to generate self-assembled calcium phosphate tubular scaffolds, which support the adhesion, survival and elongation of mesenchymal stem cells. Sodium phosphate dibasic heptahydrate can be applied to research on factitious disorders and related fields .
loading...
    loading...
Cat. No.: HY-B2200
CAS No.: 5785-44-4
Synonyms: Tricalcium dicitrate tetrahydrate, 99%
Calcium citrate tetrahydrate, 99% exhibits the ability to release more calcium ions in a short time therefore allowing a high activity, and a high concentration of calcium ions that can stimulate bone formation .
loading...
    loading...
Cat. No.: HY-W134312
CAS No.: 813-94-5
Synonyms: Tricalcium dicitrate
Calcium citrate,AR,99% (Tricalcium dicitrate) is an alkalinizing agent. Calcium citrate,AR,99% attenuates tubulointerstitial damage. Calcium citrate,AR,99% ameliorates the progression of chronic renal injury .
loading...
    loading...
Cat. No.: HY-171985
CAS No.: 4175-38-6
Research Areas:  

Others

DCPD is an amine substance with both embryotoxicity and teratogenicity, and its total effect ED50 is 0.6 μmol per egg. DCPD induces early and late embryonic death, and causes multiple embryonic malformations including microcephaly, hypoplastic optic cup, eyelid and corneal defects. DCPD can serve as a calcium phosphate additive for biomimetic α-tricalcium phosphate bone cement, which inhibits the transformation of α-tricalcium phosphate into calcium-deficient hydroxyapatite, blocks the release of Gelatins (HY-Y1365), and effectively prolongs the setting time of bone cement. DCPD is applicable to studies related to embryonic malformations .\n
loading...
    loading...